CancerInfo Center

Another Biosimilar for a Common Breast Cancer Rx
The US Food and Drug Administration (FDA) has approved another biosimilar for a common breast cancer medication.
Colorectal Cancer FAQs
There will be 101,000 new cases of colon cancer and over 44,000 new cases of rectal cancer in the United States this year, the American Cancer Society (ACS) estimates. Here's what you need to know.
Company Under Fire for Illegal Screening Tool
Total Thermal Imaging, Inc., is in the hot seat for marketing and selling an unapproved product for detecting certain diseases.
Heated Tobacco Devices: Not a Safe Option
New heated tobacco devices are not a safe alternative to smoking traditional cigarettes or using electronic cigarettes, according to a new study.
A New Biosimilar for a Breast Cancer Rx
The US Food and Drug Administration (FDA) has approved the third Herceptin (trastuzumab) biosimilar to treat certain types of cancer.
The Importance of Cancer Screenings
Skipping recommended cancer screenings could put you at risk of fatal health problems, according to a new study.
'Movember' Shines Spotlight on Men's Health
It's not just about letting your facial hair grow wild — "Movember" is about men's health, and that includes suicide, prostate cancer and testicular cancer.
Preventing Infection During Cancer Treatment
Fighting cancer often demands surgery, radiation, chemotherapy or a combination of the three, all of which have risk factors of their own. These risk factors include infections.
New Device Guides Breast Cancer Biopsies
The US Food and Drug Administration (FDA) has approved a new device to guide lymph node biopsies in patients with breast cancer.
BRCA Mutations: Who Should Get Tested?
BRCA1 and BRCA2 gene mutations increase breast cancer risk. So how do you know if you have these gene mutations?